Clinical trial
Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812
NCT00411866 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00411866 |
|---|---|
| Title | Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812 |
| Official title | Open Label Study in Healthy Volunteers to Investigate the Effect of Ketoconazole 400mg on Pharmacokinetics of SB-773812 20mg |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | SB773812, Ketoconazole |
| Enrollment | 36 |
| Start date | Oct 13, 2006 |
| Primary completion | Oct 10, 2007 |
| Completion | Oct 10, 2007 |
| First posted | Dec 15, 2006 |
| Last update posted | Aug 3, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: